We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFTG
10451
DELISTED
FormulaFolios Tactical Growth ETF
FFTG
$215K ﹤0.01%
8,727
-1,451
-14% -$38.8K
SFT
10452
CALL
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$215K ﹤0.01%
31,980
+8,110
+34% +$99.7K
BATRK icon
10453
PUT
Atlanta Braves Holdings Series B
BATRK
$3.44B
$214K ﹤0.01%
8,900
-6,800
-43% -$172K
CAAP icon
10454
Corporacion America
CAAP
$6.33B
$214K ﹤0.01%
38,368
-14,454
-27% -$89.3K
ETD icon
10455
PUT
Ethan Allen Interiors
ETD
$581M
$214K ﹤0.01%
10,600
-12,500
-54% -$295K
MIST icon
10456
PUT
Milestone Pharmaceuticals
MIST
$137M
$214K ﹤0.01%
+36,000
New +$221K
NOAH
10457
Noah Holdings
NOAH
$592M
$214K ﹤0.01%
+10,600
New +$198K
NXTC icon
10458
CALL
NextCure
NXTC
$37.6M
$214K ﹤0.01%
+3,792
New +$198K
PEJ icon
10459
PUT
Invesco Leisure and Entertainment ETF
PEJ
$314M
$214K ﹤0.01%
5,900
-7,500
-56% -$313K
PLXS icon
10460
Plexus
PLXS
$7.13B
$214K ﹤0.01%
+2,731
New +$221K
PRPH
10461
CALL
DELISTED
ProPhase Labs
PRPH
$214K ﹤0.01%
+1,690
New +$149K
SPMO icon
10462
Invesco S&P 500 Momentum ETF
SPMO
$22.3B
$214K ﹤0.01%
+4,129
New +$233K
THFF icon
10463
CALL
First Financial Corp
THFF
$976M
$214K ﹤0.01%
+4,800
New +$210K
FAZE
10464
PUT
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$214K ﹤0.01%
21,500
-142,900
-87% -$1.41M
PSTH
10465
PUT
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$214K ﹤0.01%
10,700
-163,500
-94% -$3.25M
DFUS
10466
Dimensional US Equity ETF
DFUS
$21.7B
$213K ﹤0.01%
+5,236
New +$232K
KEX icon
10467
CALL
Kirby Corp
KEX
$7.32B
$213K ﹤0.01%
3,500
-2,400
-41% -$156K
NXRT
10468
CALL
NexPoint Residential Trust
NXRT
$626M
$213K ﹤0.01%
3,400
-1,000
-23% -$76K
SPVM icon
10469
Invesco S&P 500 Value with Momentum ETF
SPVM
$133M
$213K ﹤0.01%
+4,598
New +$235K
SVM
10470
CALL
Silvercorp Metals
SVM
$2.66B
$213K ﹤0.01%
86,000
-6,600
-7% -$19.9K
WASH icon
10471
CALL
Washington Trust Bancorp
WASH
$767M
$213K ﹤0.01%
4,400
-10,500
-70% -$512K
XDSQ icon
10472
Innovator US Equity Accelerated ETF Quarterly
XDSQ
$78.2M
$213K ﹤0.01%
9,345
-3,393
-27% -$84K
SCPX
10473
DELISTED
Scorpius Holdings, Inc.
SCPX
$213K ﹤0.01%
21
+4
+24% +$40.1K
HEP
10474
PUT
DELISTED
Holly Energy Partners, L.P.
HEP
$213K ﹤0.01%
13,300
-23,100
-63% -$412K
KFYP
10475
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
$213K ﹤0.01%
7,866
-12,333
-61% -$328K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.